According to SoSoValue data, yesterday (November 28, EST) XRP spot ETF total net inflow of 22.68 million US dollars. As of press time, the total net asset value of the XRP spot ETF is 688 million US dollars, the XRP net asset ratio is 0.52%, and the historical cumulative net inflow has reached 667 million US dollars.
根据SoSoValue数据,昨日(美东时间11月28日)XRP现货ETF总净流入2268万美元。 截至发稿前,XRP现货ETF总资产净值为6.88亿美元,XRP净资产比率0.52%,历史累计净流入已达6.67亿美元。
Hong Kong biomedical stocks rebounded sharply, Rongchang Bio (09995.HK) rose more than 9.5%, WuXi Bio (02269.HK) rose more than 7.5%, WuXi PharmaTech (02268.HK) rose more than 6%, WuXi PharmaTech (02359.HK), Junshi Biosciences (01877.HK) rose more than 5%, Konoya (02162.HK), Fuhong Hanlin (02696.HK) and so on.
Hong Kong biomedical stocks fell again in the afternoon, Junshi Biosciences (01877.HK), Kailaiying (06821.HK) fell more than 7%, Nuocheng Jianhua (09969.HK) fell more than 4.5%, drug combination (02268.HK), Tiger medicine (03347.HK), Kangfang biological (09926.HK) fell more than 3%.
According to Lookonchain, BlackRock bought 4,528 BTC ($322.68 million) yesterday and held 408,253 BTC ($29.09 billion) as of October 28.
据 Lookonchain 监测,贝莱德昨日买入 4528 枚 BTC(3.2268 亿美元),截至 10 月 28 日持有 408,253 枚 BTC(290.9 亿美元)。
Hong Kong stocks "drug" fell, drug combined (02268.HK) fell more than 10%, drug Kant (02359.HK) fell more than 5%, drug biological (02269.HK) fell more than 4%.
港股“药明系”普跌,药明合联(02268.HK)跌超10%,药明康德(02359.HK)跌超5%,药明生物(02269.HK)跌超4%。